Focus on sharing individual patient data distracts from other ways of improving trial transparency

Tammy Hoffmann*, Paul Glasziou, Elaine Beller, Ben Goldacre, Iain Chalmers

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)
115 Downloads (Pure)

Abstract

The debate on sharing clinical trial data has been dominated by individual patient data. Tammy Hoffmann and colleagues argue that, although patient level data are important, a focus on the other simpler elements of trial transparency should be the first priority
Original languageEnglish
Article numberj2782
JournalBMJ (Online)
Volume357
DOIs
Publication statusPublished - 2017

    Fingerprint

Cite this